JPWO2023201324A5 - - Google Patents
Info
- Publication number
- JPWO2023201324A5 JPWO2023201324A5 JP2024560676A JP2024560676A JPWO2023201324A5 JP WO2023201324 A5 JPWO2023201324 A5 JP WO2023201324A5 JP 2024560676 A JP2024560676 A JP 2024560676A JP 2024560676 A JP2024560676 A JP 2024560676A JP WO2023201324 A5 JPWO2023201324 A5 JP WO2023201324A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- light chain
- seq
- antibody
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331716P | 2022-04-15 | 2022-04-15 | |
| US63/331,716 | 2022-04-15 | ||
| PCT/US2023/065764 WO2023201324A1 (en) | 2022-04-15 | 2023-04-14 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025512469A JP2025512469A (ja) | 2025-04-17 |
| JPWO2023201324A5 true JPWO2023201324A5 (https=) | 2026-02-02 |
| JP2025512469A5 JP2025512469A5 (https=) | 2026-02-02 |
Family
ID=88330384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560676A Pending JP2025512469A (ja) | 2022-04-15 | 2023-04-14 | 筋緊張性ジストロフィーを処置するための筋標的化複合体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250249116A1 (https=) |
| EP (1) | EP4508091A1 (https=) |
| JP (1) | JP2025512469A (https=) |
| KR (1) | KR20250004769A (https=) |
| CN (1) | CN119256008A (https=) |
| AU (1) | AU2023253710A1 (https=) |
| CA (1) | CA3248961A1 (https=) |
| IL (1) | IL315944A (https=) |
| MX (1) | MX2024012737A (https=) |
| WO (1) | WO2023201324A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US20250339553A1 (en) | 2022-04-15 | 2025-11-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating myotonic dystrophy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012007896A1 (en) * | 2010-07-12 | 2012-01-19 | Covx Technologies Ireland, Ltd. | Multifunctional antibody conjugates |
| AU2021318851A1 (en) * | 2020-07-23 | 2023-03-16 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
-
2023
- 2023-04-14 EP EP23789168.4A patent/EP4508091A1/en active Pending
- 2023-04-14 KR KR1020247037612A patent/KR20250004769A/ko active Pending
- 2023-04-14 CN CN202380034350.7A patent/CN119256008A/zh active Pending
- 2023-04-14 US US18/856,247 patent/US20250249116A1/en active Pending
- 2023-04-14 WO PCT/US2023/065764 patent/WO2023201324A1/en not_active Ceased
- 2023-04-14 IL IL315944A patent/IL315944A/en unknown
- 2023-04-14 CA CA3248961A patent/CA3248961A1/en active Pending
- 2023-04-14 AU AU2023253710A patent/AU2023253710A1/en active Pending
- 2023-04-14 JP JP2024560676A patent/JP2025512469A/ja active Pending
-
2024
- 2024-10-14 MX MX2024012737A patent/MX2024012737A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL315944A (en) | Muscle targeting complexes and uses thereof for treating myotonic dystrophy | |
| IL316143A (en) | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy | |
| IL316206A (en) | Dosage of muscle targeting complexes for the treatment of myotonic dystrophy | |
| IL309910A (en) | Muscle targeting complexes and their uses for the treatment of myotonic dystrophy | |
| IL309936A (en) | Muscle targeting complexes and formulations for the treatment of dystrophinopathy | |
| IL320340A (en) | Muscle targeting complexes and uses thereof for skipping exon 45 of a dmd gene | |
| JPWO2021142234A5 (https=) | ||
| JP2024160045A5 (https=) | ||
| IL312170A (en) | Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy | |
| IL317871A (en) | Muscle targeting complexes and their uses for the treatment of FACIOSCAPULOHUMERAL muscular dystrophy | |
| IL309912A (en) | Muscle targeting complexes and their uses for the treatment of dystrophinopathy | |
| JPWO2023201324A5 (https=) | ||
| IL309935A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL309911A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL309909A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL309937A (en) | Muscle targeting complexes and uses thereof for treating dystrophinopathies | |
| IL312142A (en) | Muscle targeting complexes for the treatment of dystrophinopathy | |
| JPWO2021142307A5 (https=) | ||
| JPWO2022026152A5 (https=) | ||
| JPWO2018129384A5 (https=) | ||
| IL322946A (en) | Methods and compositions for inhibiting the progression of intramuscular fibrosis | |
| JPWO2021142227A5 (https=) | ||
| JPWO2022147209A5 (https=) | ||
| JPWO2023283615A5 (https=) | ||
| JPWO2021142275A5 (https=) |